Author:
Zhu Jun-Ren,Zhang Shu-Yang,Gao Ping-Jin
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference33 articles.
1. Bakris, G. L., Sarafidis, P. A., Weir, M. R., Dahlof, B., Pitt, B., Jamerson, K., Velazquez, E. J.,Staikos-Byrne, L., Kelly, R. Y., Shi, V., Chiang, Y. T., Weber, M. A. and ACCOMPLISH Trial investigators.(2010). Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 375: 1173–1181.
2. Bangalore, S., G. Kamalakkannan, S. Parkar, and F.H. Messerli. 2007. Fixed-dose combinations improve medication compliance: A meta-analysis. American Journal of Medicine 120: 713–719.
3. Chen, X., P. Hu, J. Jiang, T. Liu, W. Zhong, H. Liu, and Q. Zhao. 2012. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females. Clinical Drug Investigation 32: 783–790.
4. Chrysant, S.G., J. Lee, M. Melino, S. Karki, and R. Heyrman. 2010. Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension. Journal of Human Hypertension 24: 730–738.
5. Chrysant, S.G., M. Melino, S. Karki, J. Lee, and R. Heyrman. 2008. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clinical Therapeutics 30: 587–604.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献